Amedeo Smart

Free Medical Literature Service

 

Amedeo

Osteoporosis
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    April 2024
  1. LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
    Impact of oral bisphosphonate drug holiday on mortality following hip fracture: a population-based cohort study.
    J Clin Endocrinol Metab. 2024 Apr 17:dgae272. doi: 10.1210.
    >> Share

  2. KAMANDA-KOSSEH M, Shiau S, Agarwal S, Kondapalli A, et al
    Bisphosphonates Maintain BMD after Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2024 Apr 12:dgae240. doi: 10.1210.
    >> Share

  3. ZHANG X, Cheung KS, Mak LY, Tan KCB, et al
    Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae223. doi: 10.1210.
    >> Share

    March 2024
  4. HE D, Liu H, Zhao Y, Wei W, et al
    Assessing the interaction effects of mitochondrial DNA polymorphisms and lifestyle on heel bone mineral density.
    J Clin Endocrinol Metab. 2024 Mar 27:dgae195. doi: 10.1210.
    >> Share

  5. STOKAR J, Szalat A
    Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
    J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210.
    >> Share

    February 2024
  6. TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al
    More rapid bone mineral density loss in older men with diabetes: The Osteoporotic Fractures in Men (MrOS) Study.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210.
    >> Share

  7. MORI Y, Mori N
    Letter to the Editor From Mori and Mori: "Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis".
    J Clin Endocrinol Metab. 2024 Feb 9:dgae083. doi: 10.1210.
    >> Share

    January 2024
  8. MINISOLA S, Cipriani C, Colangelo L, Pepe J, et al
    At the Intersection Between Skeletal and Hematopoietic Systems: Incorporating Hemoglobin in FRAX(R).
    J Clin Endocrinol Metab. 2024;109:e856-e857.
    >> Share

  9. BAUER DC, Black DM, Dell R, Fan B, et al
    Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case Cohort Study with Blinded Radiographic Review.
    J Clin Endocrinol Metab. 2024 Jan 10:dgae023. doi: 10.1210.
    >> Share

    December 2023
  10. STYRKARSDOTTIR U, Tragante V, Stefansdottir L, Thorleifsson G, et al
    Obesity variants in the GIPR gene do not associate with risk of fracture or bone mineral density.
    J Clin Endocrinol Metab. 2023 Dec 20:dgad734. doi: 10.1210.
    >> Share

  11. PRINCE RL
    New Data on the Increased hip Fracture Risk in Type 2 Diabetes and Its Reduction in Those With High Physical Activity.
    J Clin Endocrinol Metab. 2023 Dec 14:dgad712. doi: 10.1210.
    >> Share

    November 2023
  12. WANG M, Seibel MJ
    Approach to the Patient With Bone Fracture: Making the First Fracture the Last.
    J Clin Endocrinol Metab. 2023;108:3345-3352.
    >> Share

    October 2023
  13. ZHANG X, Chen X, Li S, Gao M, et al
    Association between advanced glycation end products and sarcopenia: The mediating role of osteoporosis.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad640. doi: 10.1210.
    >> Share

    September 2023
  14. FAVERO V, Eller-Vainicher C, Morelli V, Cairoli E, et al
    Increased risk of vertebral fractures in patients with mild autonomous cortisol secretion.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad560. doi: 10.1210.
    >> Share

  15. ANAGNOSTIS P, Lampropoulou-Adamidou K, Bosdou JK, Trovas G, et al
    Comparative effectiveness of therapeutic interventions in pregnancy and lactation-associated osteoporosis: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2023 Sep 14:dgad548. doi: 10.1210.
    >> Share

    August 2023
  16. FLOKAS ME, Wakim P, Kollender S, Sinaii N, et al
    Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2023 Aug 29:dgad514. doi: 10.1210.
    >> Share

  17. RAMCHAND SK, Leder BZ
    Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad496. doi: 10.1210.
    >> Share

  18. PHUNG K, McAdam L, Ma J, McMillan HJ, et al
    Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad435. doi: 10.1210.
    >> Share

  19. SZULC P, Lewis JR, Chapurlat R
    Accelerated bone loss in older men with severe abdominal aortic calcification - the prospective MINOS study.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad459. doi: 10.1210.
    >> Share

  20. CHILOIRO S, Frara S, Gagliardi I, Bianchi A, et al
    Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly.
    J Clin Endocrinol Metab. 2023 Aug 22:dgad493. doi: 10.1210.
    >> Share

  21. SOTO-PEDRE E, Lin YY, Soto-Hernaez J, Newey PJ, et al
    Morbidity Associated With Primary Hyperparathyroidism-A Population-based Study With a Subanalysis on Vitamin D.
    J Clin Endocrinol Metab. 2023;108:e842-e849.
    >> Share

  22. LIN SY, Chen WJ, Ku CK, Chen YM, et al
    Treatment Persistence and Medication Switch Associated with Subsequent Fractures after Osteoporotic Fractures.
    J Clin Endocrinol Metab. 2023 Aug 1:dgad449. doi: 10.1210.
    >> Share

    July 2023
  23. LABAYEN I, Cadenas-Sanchez C, Idoate F, Medrano M, et al
    Liver fat, bone marrow adipose tissue and bone mineral density in children with overweight.
    J Clin Endocrinol Metab. 2023 Jul 25:dgad429. doi: 10.1210.
    >> Share

  24. CAPPOLA AR, Auchus RJ, El-Hajj Fuleihan G, Handelsman DJ, et al
    Hormones and Aging: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2023;108:1835-1874.
    >> Share

  25. TRINH A, Milat F
    Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial.
    J Clin Endocrinol Metab. 2023 Jul 12:dgad386. doi: 10.1210.
    >> Share

  26. JAISWAL R, Johansson H, Axelsson KF, Magnusson P, et al
    Hemoglobin levels improve fracture risk prediction in addition to FRAX(R) clinical risk factors and bone mineral density.
    J Clin Endocrinol Metab. 2023 Jul 5:dgad399. doi: 10.1210.
    >> Share

    June 2023
  27. WATTS NB, Leslie WD
    Letter to the Editor from Watts and William: Comparisons between different anti-osteoporosis medications on postfracture mortality: a population-based study.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad317. doi: 10.1210.
    >> Share

    May 2023
  28. GRANILD-JENSEN JB, Moller-Madsen B, Rackauskaite G, Farholt S, et al
    Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial.
    J Clin Endocrinol Metab. 2023 May 26:dgad299. doi: 10.1210.
    >> Share

  29. CARBONE L, Buzkova P, Fink HA, Robbins JA, et al
    Plasma Levels of Branched Chain Amino Acids, Incident Hip Fractures and Bone Mineral Density of the Hip and Spine.
    J Clin Endocrinol Metab. 2023 May 18:dgad275. doi: 10.1210.
    >> Share

  30. SKJODT MK, Abrahamsen B
    New insights in the pathophysiology, epidemiology and response to treatment of osteoporotic vertebral fractures.
    J Clin Endocrinol Metab. 2023 May 15:dgad256. doi: 10.1210.
    >> Share

  31. HO-LE TP, Tran TS, Nguyen HG, Center JR, et al
    Genetic prediction of lifetime risk of fracture.
    J Clin Endocrinol Metab. 2023 May 11:dgad254. doi: 10.1210.
    >> Share

  32. MEIER C, Eastell R, Pierroz DD, Lane NE, et al
    Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS.
    J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210.
    >> Share

  33. MEIER C, Eastell R, Pierroz DD, Lane NE, et al
    Biochemical Markers of Bone Fragility in Patients With Diabetes.
    J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210.
    >> Share

    April 2023
  34. PACCOU J, Badr S, Lombardo D, Khizindar H, et al
    Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women: The ADIMOS Case-Control Study.
    J Clin Endocrinol Metab. 2023 Apr 5:dgad195. doi: 10.1210.
    >> Share

    March 2023
  35. FAN W, Leder BZ, Bolster MB
    Response to Letter to the Editor from Riahi and Gruntmanis: 'Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates'.
    J Clin Endocrinol Metab. 2023 Mar 22:dgad161. doi: 10.1210.
    >> Share

  36. RIAHI S, Gruntmanis U
    "Letter to the Editor from Riahi and Gruntmanis: 'Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates'.
    J Clin Endocrinol Metab. 2023 Mar 22:dgad162. doi: 10.1210.
    >> Share

    February 2023
  37. HEILBRONNER AK, Koff MF, Breighner R, Kim HJ, et al
    Opportunistic Evaluation of Trabecular Bone Texture by MRI Reflects Bone Mineral Density and Microarchitecture.
    J Clin Endocrinol Metab. 2023 Feb 17:dgad082. doi: 10.1210.
    >> Share

    January 2023
  38. LIU W, Lee B, Nagamani SCS, Nicol L, et al
    Approach to the Patient: Pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta.
    J Clin Endocrinol Metab. 2023 Jan 20:dgad035. doi: 10.1210.
    >> Share

  39. ZENG H, Ge J, Xu W, Ma H, et al
    Twelve Loci Associated With Bone Density in Middle-aged and Elderly Chinese: The Shanghai Changfeng Study.
    J Clin Endocrinol Metab. 2023;108:295-305.
    >> Share

  40. HU J, Lin X, Gao P, Zhang Q, et al
    Genotypic and phenotypic spectrum and pathogenesis of WNT1 variants in a large cohort of patients with OI/osteoporosis.
    J Clin Endocrinol Metab. 2023 Jan 3:dgac752. doi: 10.1210.
    >> Share

    December 2022
  41. VAN ABSWOUDE DH, Pellikaan K, Rosenberg AGW, Davidse K, et al
    Bone Health in Adults With Prader-Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study.
    J Clin Endocrinol Metab. 2022;108:59-84.
    >> Share

  42. ADLER RA
    Osteoporosis Treatment: Decreased Mortality Too?
    J Clin Endocrinol Metab. 2022 Dec 15:dgac723. doi: 10.1210.
    >> Share

  43. WANG M, Chen X, Cui W, Wang X, et al
    A computed tomography-based radiomics nomogram for predicting osteoporotic vertebral fractures: A longitudinal study.
    J Clin Endocrinol Metab. 2022 Dec 10:dgac722. doi: 10.1210.
    >> Share

  44. DIMAI HP
    New Horizons: AI tools for managing osteoporosis.
    J Clin Endocrinol Metab. 2022 Dec 8:dgac702. doi: 10.1210.
    >> Share

    November 2022
  45. GAGNON C
    Reduced Intestinal Calcium Absorption Correlates with Bone Loss After Sleeve Gastrectomy: Implications for Clinical Care.
    J Clin Endocrinol Metab. 2022 Nov 24:dgac681. doi: 10.1210.
    >> Share

  46. MESSNER Z, Carro-Vazquez D, Haschka J, Grillari J, et al
    Circulating miRNAs Respond to Denosumab Treatment after Two Years in Postmenopausal Women with Osteoporosis.
    J Clin Endocrinol Metab. 2022 Nov 19:dgac667. doi: 10.1210.
    >> Share

  47. WU CH, Li CC, Hsu YH, Liang FW, et al
    Comparisons between different anti-osteoporosis medications on postfracture mortality: A population-based study.
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785916. doi: 10.1210.
    >> Share

    October 2022
  48. KLINE GA, Morin SN, Lix LM, McCloskey EV, et al
    General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study.
    J Clin Endocrinol Metab. 2022 Oct 6. pii: 6750025. doi: 10.1210.
    >> Share

    September 2022
  49. REID IR
    How Often Should We Measure Bone Density?
    J Clin Endocrinol Metab. 2022;107:e4267-e4268.
    >> Share

  50. FAN W, Machado M, Leder BZ, Beyer L, et al
    Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691222. doi: 10.1210.
    >> Share

  51. LI I, Hartley IR, Klubo-Gwiedzdzinska J, Reynolds JC, et al
    Fracture Risk in Pediatric Patients with MEN2B.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691128. doi: 10.1210.
    >> Share

    August 2022
  52. SINGH S, Morshed S, Motamedi D, Kidane J, et al
    Identification of Risk Factors in the Development of Heterotopic Ossification After Primary Total Hip Arthroplasty.
    J Clin Endocrinol Metab. 2022;107:e3944-e3952.
    >> Share

  53. MATSUMOTO T, Sone T, Soen S, Tanaka S, et al
    Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study.
    J Clin Endocrinol Metab. 2022 Aug 17. pii: 6670847. doi: 10.1210.
    >> Share

    July 2022
  54. LYU H, Zhao S, Li J, Li X, et al
    Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:e3366-e3373.
    >> Share

    June 2022
  55. OHEIM R, Tsourdi E, Seefried L, Beller G, et al
    Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
    J Clin Endocrinol Metab. 2022;107:e3048-e3057.
    >> Share

    May 2022
  56. ENSRUD KE, Lui LY, Crandall CJ, Orwoll ES, et al
    Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2022 May 19. pii: 6589466. doi: 10.1210.
    >> Share

  57. COMNINOS AN, Hansen MS, Courtney A, Choudhury S, et al
    Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
    J Clin Endocrinol Metab. 2022;107:1529-1540.
    >> Share

  58. CIUFFI S, Marini F, Fossi C, Donati S, et al
    Circulating microRNAs as biomarkers of osteoporosis and fragility fractures.
    J Clin Endocrinol Metab. 2022 May 9. pii: 6582745. doi: 10.1210.
    >> Share

  59. CARWILE JL, Seshasayee SM, Ahrens KA, Hauser R, et al
    Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.
    J Clin Endocrinol Metab. 2022 May 3. pii: 6575101. doi: 10.1210.
    >> Share

    April 2022
  60. AGARWAL S, Shane E, Lang T, Shiau S, et al
    Spine volumetric BMD and strength in premenopausal idiopathic osteoporosis: Effects of teriparatide followed by denosumab.
    J Clin Endocrinol Metab. 2022 Apr 16. pii: 6569192. doi: 10.1210.
    >> Share

  61. YOO JE, Yoon JW, Park HE, Han K, et al
    Response to Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563352. doi: 10.1210.
    >> Share

  62. ZHOU Q
    Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563351. doi: 10.1210.
    >> Share

    March 2022
  63. FRARA S, Uygur MM, di Filippo L, Doga M, et al
    High Prevalence of Vertebral Fractures Associated with Preoperative GH Levels in Patients with recent Diagnosis of Acromegaly.
    J Clin Endocrinol Metab. 2022 Mar 29. pii: 6555665. doi: 10.1210.
    >> Share

  64. BORN C, Jakob F, Shojaa M, Kohl M, et al
    Effects of hormone therapy and exercise on bone mineral density in healthy women - A systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2022 Mar 24. pii: 6553368. doi: 10.1210.
    >> Share

  65. PENA DIAS J, Piggott DA, Sun J, Wehbeh L, et al
    SHBG, bone mineral density and physical function among injection drug users with and without HIV and HCV.
    J Clin Endocrinol Metab. 2022 Mar 16. pii: 6549479. doi: 10.1210.
    >> Share

    February 2022
  66. BALEANU F, Moreau M, Charles A, Iconaru L, et al
    Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study.
    J Clin Endocrinol Metab. 2022 Feb 17. pii: 6530319. doi: 10.1210.
    >> Share

    January 2022
  67. COLL JC, Garceau E, Leslie WD, Genest M, et al
    Prevalence of Vertebral Fractures in Adults with Type 1 Diabetes: DenSiFy Study (Diabetes Spine Fractures).
    J Clin Endocrinol Metab. 2022 Jan 28. pii: 6517001. doi: 10.1210.
    >> Share

  68. KLINE GA, Morin SN, Lix LM, Leslie WD, et al
    Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:491-499.
    >> Share

    December 2021
  69. QUESTER J, Nethander M, Eriksson A, Ohlsson C, et al
    Endogenous DHEAS is Causally Linked with Lumbar Spine Bone Mineral Density and Forearm Fractures in Women.
    J Clin Endocrinol Metab. 2021 Dec 22. pii: 6479181. doi: 10.1210.
    >> Share

  70. COSENTINI D, Grisanti S, Hadoux J, Libe R, et al
    Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461116. doi: 10.1210.
    >> Share

  71. WANG B, Wang Z, Poundarik AA, Zaki MJ, et al
    Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.
    J Clin Endocrinol Metab. 2021 Dec 9. pii: 6458464. doi: 10.1210.
    >> Share

    November 2021
  72. YOO JE, Yoon JW, Park HE, Han K, et al
    Blood pressure variability and the risk of fracture: a nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Nov 28. pii: 6445180. doi: 10.1210.
    >> Share

  73. SHANE E, Shiau S, Recker RR, Lappe JM, et al
    Denosumab After Teriparatide in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2021 Nov 24. pii: 6437931. doi: 10.1210.
    >> Share

  74. DAWOOD NB, Tseng CH, Nguyen DT, Yan KL, et al
    Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    J Clin Endocrinol Metab. 2021;106:e4993-e5000.
    >> Share

    October 2021

  75. Corrigendum to: Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6410701. doi: 10.1210.
    >> Share

    September 2021
  76. FERRARI S
    Short or long-term osteoporosis therapy with denosumab ?
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375342. doi: 10.1210.
    >> Share

  77. SHIEH A, Ruppert KM, Greendale GA, Lian Y, et al
    Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women.
    J Clin Endocrinol Metab. 2021 Sep 19. pii: 6372418. doi: 10.1210.
    >> Share

    August 2021
  78. VIOLA V, Tramontana F, Leanza G
    Letter to the Editor from Viola Viola: "Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis".
    J Clin Endocrinol Metab. 2021 Aug 14. pii: 6352412. doi: 10.1210.
    >> Share

  79. KARAKILIC E, Saygili ES
    Letter to the Editor From Karakilic and Saygili:" Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes".
    J Clin Endocrinol Metab. 2021 Aug 13. pii: 6350455. doi: 10.1210.
    >> Share

  80. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Response letter to the Editor from Dr. Viola et al. "Diminishing value from multiple serial bone densitometry in women receiving antiresorptive medication for osteoporosis."
    J Clin Endocrinol Metab. 2021 Aug 7. pii: 6345421. doi: 10.1210.
    >> Share

  81. CROMER SJ, Yu EW
    Challenges and opportunities for osteoporosis care during the COVID-19 pandemic.
    J Clin Endocrinol Metab. 2021 Aug 3. pii: 6337853. doi: 10.1210.
    >> Share

    July 2021
  82. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    >> Share

  83. KUZMA M, Vanuga P, Sagova I, Pavai D, et al
    Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.
    J Clin Endocrinol Metab. 2021 Jul 16. pii: 6322668. doi: 10.1210.
    >> Share

  84. SCHMITZ D, Ek WE, Berggren E, Hoglund J, et al
    Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320117. doi: 10.1210.
    >> Share

  85. WARD LM, Ma J, Robinson ME, Scharke M, et al
    Osteoporotic Fractures and Vertebral Body Reshaping in Children with Glucocorticoid-Treated Rheumatic Disorders.
    J Clin Endocrinol Metab. 2021 Jul 7. pii: 6316730. doi: 10.1210.
    >> Share

  86. WARD LM, Choudhury A, Alos N, Cabral DA, et al
    Zoledronic acid versus placebo in pediatric glucocorticoid-induced osteoporosis: A randomized double-blind phase 3 trial.
    J Clin Endocrinol Metab. 2021 Jul 6. pii: 6316209. doi: 10.1210.
    >> Share

  87. LING CW, Miao Z, Xiao ML, Zhou H, et al
    The Association of Gut Microbiota with Osteoporosis is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313243. doi: 10.1210.
    >> Share

  88. MITCHELL A, Fall T, Melhus H, Lind L, et al
    Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313244. doi: 10.1210.
    >> Share

    June 2021
  89. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    >> Share

  90. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    >> Share

  91. CHAPURLAT R
    Of the Futility of Repeating BMD Measurement in Treated Osteoporotic Women.
    J Clin Endocrinol Metab. 2021 Jun 17. pii: 6303538. doi: 10.1210.
    >> Share

    May 2021
  92. KIM JA, Lee JS, Song E, Roh E, et al
    Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
    >> Share

  93. ZAWORSKI C, Cheah J, Koff MF, Breighner R, et al
    MRI-based texture analysis of trabecular bone for opportunistic screening of skeletal fragility.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6276953. doi: 10.1210.
    >> Share

  94. MAKRAS P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, et al
    The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.
    J Clin Endocrinol Metab. 2021 May 12. pii: 6274510. doi: 10.1210.
    >> Share

  95. ZHU J, Briganti EM
    Letter to the Editor from Jasmine Zhu: Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2021 May 6. pii: 6268612. doi: 10.1210.
    >> Share


  96. Corrigendum to: "Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT".
    J Clin Endocrinol Metab. 2021 May 4. pii: 6263815. doi: 10.1210.
    >> Share

    April 2021
  97. SHIEH A, Karlamangla AS, Huang MH, Han W, et al
    Faster lumbar spine bone loss in midlife predicts subsequent fracture independent of starting bone mineral density.
    J Clin Endocrinol Metab. 2021 Apr 27. pii: 6254916. doi: 10.1210.
    >> Share

  98. CIARDULLO S, Muraca E, Zerbini F, Manzoni G, et al
    NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population.
    J Clin Endocrinol Metab. 2021 Apr 20. pii: 6241840. doi: 10.1210.
    >> Share

    March 2021
  99. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Diminishing value from multiple serial bone densitometry in women receiving anti-resorptive medication for osteoporosis.
    J Clin Endocrinol Metab. 2021 Mar 30. pii: 6204740. doi: 10.1210.
    >> Share

  100. REEVES KW, Vieyra G, Grimes NP, Meliker J, et al
    Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6180137. doi: 10.1210.
    >> Share

  101. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    >> Share

  102. XUE S, Zhang Y, Qiao W, Zhao Q, et al
    An Updated Reference for Calculating Bone Mineral Density T-Scores.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178347. doi: 10.1210.
    >> Share

  103. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
    Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
    >> Share

  104. GONG R, Xiao HM, Zhang YH, Zhao Q, et al
    Identification and Functional Characterization of Metabolites for Bone Mass in Peri-/Post-menopausal Chinese Women.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6161511. doi: 10.1210.
    >> Share

    February 2021

  105. Corrigendum to: "Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health Initiative".
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146952. doi: 10.1210.
    >> Share

  106. QU Z, Yang F, Yan Y, Hong J, et al
    Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2021 Feb 13. pii: 6134779. doi: 10.1210.
    >> Share

  107. CIPRIANI C, Minisola S, Bilezikian JP, Diacinti D, et al
    Vertebral Fracture Assessment in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132444. doi: 10.1210.
    >> Share

  108. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
    In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
    J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
    >> Share

    January 2021
  109. KONG SH, Kim JH, Shin CS
    Serum Spermidine as a Novel Potential Predictor for Fragility Fractures.
    J Clin Endocrinol Metab. 2021;106:e582-e591.
    >> Share

  110. MISRA M, Bredella MA
    Bone Metabolism in Adolescents Undergoing Bariatric Surgery.
    J Clin Endocrinol Metab. 2021;106:326-336.
    >> Share

  111. DREYER P, Palomo T, Brandao CMA, Vieira JGH, et al
    Letter to the Editor from Dreyer, et al: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 22. pii: 6114543. doi: 10.1210.
    >> Share

  112. YUAN S, Wan ZH, Cheng SL, Michaelsson K, et al
    Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jan 19. pii: 6104229. doi: 10.1210.
    >> Share


  113. Corrigendum to: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 13. pii: 6094895. doi: 10.1210.
    >> Share

  114. HANNEMANN A, Nauck M, Volzke H, Weidner H, et al
    Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
    J Clin Endocrinol Metab. 2021;106:e288-e299.
    >> Share

    November 2020
  115. FENG SH, Huang YP, Yeh KC, Pan SL, et al
    Osteoporosis and the risk of Parkinson's disease: A nationwide propensity score-matched longitudinal follow-up study.
    J Clin Endocrinol Metab. 2020 Nov 25. pii: 6000490. doi: 10.1210.
    >> Share

  116. BROADWELL A, Chines A, Ebeling PR, Franek E, et al
    Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2020 Nov 19. pii: 5992310. doi: 10.1210.
    >> Share

  117. HOFSO D, Hillestad TOW, Halvorsen E, Fatima F, et al
    Bone mineral density and bone turnover after sleeve gastrectomy and gastric bypass, a randomized controlled trial.
    J Clin Endocrinol Metab. 2020 Nov 5. pii: 5956311. doi: 10.1210.
    >> Share

  118. CHARLIER S, Vavanikunnel J, Becker C, Jick SS, et al
    Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
    J Clin Endocrinol Metab. 2020 Nov 3. pii: 5952698. doi: 10.1210.
    >> Share

    October 2020
  119. TSOURDI E, Zillikens MC, Meier C, Body JJ, et al
    Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
    J Clin Endocrinol Metab. 2020 Oct 26. pii: 5939974. doi: 10.1210.
    >> Share

  120. DI FILIPPO L, Formenti AM, Doga M, Pedone E, et al
    Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes.
    J Clin Endocrinol Metab. 2020 Oct 21. pii: 5923308. doi: 10.1210.
    >> Share

    September 2020
  121. KREZ A, Agarwal S, Bucovsky M, McMahon DJ, et al
    Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906394. doi: 10.1210.
    >> Share

    May 2020
  122. YEAP BB, Alfonso H, Chubb SAP, Center JR, et al
    U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
    J Clin Endocrinol Metab. 2020;105.
    >> Share

    April 2020
  123. NETHANDER M, Pettersson-Kymmer U, Vandenput L, Lorentzon M, et al
    BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure.
    J Clin Endocrinol Metab. 2020;105.
    >> Share

  124. GREY A, Horne A, Gamble G, Mihov B, et al
    Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    J Clin Endocrinol Metab. 2020;105.
    >> Share

    March 2020
  125. CIPRIANI C, Bilezikian JP
    Osteoanabolics Versus Antiresorptives: Which First?
    J Clin Endocrinol Metab. 2020;105.
    >> Share

    December 2019
  126. SHIEH A, Greendale GA, Cauley JA, Karlamangla AS, et al
    The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
    J Clin Endocrinol Metab. 2019 Dec 16. pii: 5678661. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016